In agreement with the inhibition of PI3K, we found that the combination of 10058-F4 with AT7519 resulted in a superior cytotoxicity in KG-1 cells (Figure 2); suggesting that either direct or indirect suppression of c-Myc could be a profitable strategy to boost the anti-cancer effect of CDK inhibitors in acute leukemia. This evidence concerns the gene MYC and cancer.